Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$1.27B |
| 2 |
iShares MSCI Emerging Markets ETF
EEM
|
+$1.23B |
| 3 |
SPDR Gold Trust
GLD
|
+$710M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$662M |
| 5 |
Abbott
ABT
|
+$459M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.33B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$932M |
| 3 |
TransDigm Group
TDG
|
+$833M |
| 4 |
MPLX
MPLX
|
+$616M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$593M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 11.4% |
| 2 | Financials | 10.07% |
| 3 | Consumer Discretionary | 8.39% |
| 4 | Healthcare | 7.69% |
| 5 | Communication Services | 6.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
LTC
3026
LTC Properties
LTC
$2.15B
| $4.79M | ﹤0.01% |
126,069
-3,245
| -3% | -$128K |
|
3027
Stride
LRN
$3.43B
| $4.78M | ﹤0.01% |
337,201
+42,719
| +15% | +$669K |
|
3028
8x8 Inc
EGHT
$332M
| $4.78M | ﹤0.01% |
256,245
+65,650
| +34% | +$1.16M |
|
|
XLRN
3029
DELISTED
Acceleron Pharma
XLRN
| $4.78M | ﹤0.01% |
122,224
+15,454
| +14% | +$657K |
|
|
MTGE
3030
DELISTED
MTGE Investment Corp. Common Stock
MTGE
| $4.78M | ﹤0.01% |
267,003
-116,332
| -30% | -$2.06M |
|
3031
Lloyds Banking Group
LYG
$91.3B
| $4.77M | ﹤0.01% |
1,283,280
+30,973
| +2% | +$120K |
|
3032
QuidelOrtho
QDEL
$838M
| $4.77M | ﹤0.01% |
92,053
+5,601
| +6% | +$261K |
|
3033
State Street SPDR S&P 400 Mid Cap Value ETF
MDYV
$2.83B
| $4.77M | ﹤0.01% |
95,868
+36,850
| +62% | +$1.88M |
|
|
UHT
3034
Universal Health Realty Income Trust
UHT
$594M
| $4.77M | ﹤0.01% |
79,310
+15,331
| +24% | +$958K |
|
|
GTT
3035
DELISTED
GTT Communications, Inc.
GTT
| $4.76M | ﹤0.01% |
83,978
-29,250
| -26% | -$1.44M |
|
3036
Smith & Wesson
SWBI
$637M
| $4.76M | ﹤0.01% |
599,972
+130,638
| +28% | +$1.1M |
|
|
AD
3037
Array Digital Infrastructure
AD
$3.05B
| $4.75M | ﹤0.01% |
118,262
-27,243
| -19% | -$1.01M |
|
|
NAV
3038
DELISTED
Navistar International
NAV
| $4.75M | ﹤0.01% |
135,719
-51,879
| -28% | -$2.09M |
|
3039
Terreno Realty
TRNO
$7.49B
| $4.74M | ﹤0.01% |
137,330
-1,700
| -1% | -$58.3K |
|
3040
FormFactor
FORM
$9.17B
| $4.73M | ﹤0.01% |
346,674
+171,350
| +98% | +$2.48M |
|
|
EDF
3041
Virtus Stone Harbor Emerging Markets Income Fund
EDF
$171M
| $4.73M | ﹤0.01% |
297,182
+16,024
| +6% | +$257K |
|
3042
MGP Ingredients
MGPI
$375M
| $4.73M | ﹤0.01% |
52,772
+5,341
| +11% | +$434K |
|
3043
Kadant
KAI
$3.99B
| $4.73M | ﹤0.01% |
50,014
-6,917
| -12% | -$680K |
|
|
JCAP
3044
DELISTED
Jernigan Capital, Inc.
JCAP
| $4.72M | ﹤0.01% |
260,870
+3,495
| +1% | +$62.3K |
|
|
STK
3045
Columbia Seligman Premium Technology Growth Fund
STK
$926M
| $4.71M | ﹤0.01% |
214,531
-20,948
| -9% | -$473K |
|
|
XENT
3046
DELISTED
Intersect ENT, Inc
XENT
| $4.7M | ﹤0.01% |
119,664
-19,200
| -14% | -$701K |
|
|
HTO
3047
H2O America
HTO
$2.62B
| $4.7M | ﹤0.01% |
89,157
-4,087
| -4% | -$230K |
|
3048
State Street SPDR S&P Telecom ETF
XTL
$586M
| $4.7M | ﹤0.01% |
68,187
+46,600
| +216% | +$3.26M |
|
3049
Nuveen California Municipal Value Fund
NCA
$302M
| $4.69M | ﹤0.01% |
502,935
+14,105
| +3% | +$137K |
|
3050
Tronox
TROX
$1.04B
| $4.69M | ﹤0.01% |
254,339
-126,818
| -33% | -$2.53M |
|
Similar funds
Morgan Stanley's Q1 2018 Portfolio in Review
As of Q1 2018, Morgan Stanley held 6,930 positions worth $360B, down 1.4% from $365B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Trading was light in Q1 2018: portfolio turnover was 4.7%. Morgan Stanley opened 171 new positions and exited 156, leaving the 6,930-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 11% of assets, up from 11% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q1 2018 buy was Nutrien: 1,554,481 shares worth $73.5M.
- Morgan Stanley added most to iShares Russell 2000 ETF in Q1 2018, an estimated $1.27B increase.
- Morgan Stanley's biggest Q1 2018 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.33B.
- Morgan Stanley fully exited Juno Therapeutics, Inc. in Q1 2018, selling an estimated $86M.
- Morgan Stanley's ten largest holdings make up 14% of its $360B portfolio in Q1 2018.
- Morgan Stanley opened 171 new positions and closed 156 in Q1 2018.
- Morgan Stanley's portfolio value fell 1.4% quarter-over-quarter to $360B.
Based on Morgan Stanley's 13F filing for Q1 2018, filed 14 May 2018.